Physician

Milan Bajmoczi, M.D.

According to 2025 Medicare claims, Milan Bajmoczi, M.D. (NPI: 1700012598) practices vascular surgery in the Fairbanks-College, AK market, with the plurality of this provider's patient population coming from Fairbanks North Star, AK. This provider's primary affiliated billing organization is FAIRBANKS VASCULAR SURGERY (NPI: 1972240562; TIN: 882204045) and primary practice location at 99709-4873.

Bajmoczi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 324 traditional Medicare patients, billed 1,882 HCPCS/CPT codes, and received $443,189 in Medicare payments. The top billing code was 93970 (Ultrasound study of arm or leg veins with compression and maneuvers). Part D data shows 114 prescription claims across 44 beneficiaries totaling $13,705 in drug costs, led by Clopidogrel (Clopidogrel Bisulfate). Open Payments data shows 5 records totaling $35,182. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $182,546 to $443,189. Similarly, Part D prescription costs have risen steadily, from $1,003 to $13,705. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$377K$754K2015 Medicare payment: $182,546 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $186,574 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $151,580 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $149,785 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $144,357 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $149,313 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $150,804 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $178,942 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $753,862 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $443,189 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153231,444$182,546
20163991,881$186,574
20174371,640$151,580
20185571,776$149,785
20195561,715$144,357
20204991,599$149,313
20215751,647$150,804
20223941,175$178,942
20233982,368$753,862
20243241,882$443,189

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$12K$23K2015 Drug cost: $1,003 (USD; Tot_Drug_Cst)2016 Drug cost: $3,900 (USD; Tot_Drug_Cst)2017 Drug cost: $8,071 (USD; Tot_Drug_Cst)2018 Drug cost: $2,783 (USD; Tot_Drug_Cst)2019 Drug cost: $7,387 (USD; Tot_Drug_Cst)2020 Drug cost: $22,356 (USD; Tot_Drug_Cst)2021 Drug cost: $11,342 (USD; Tot_Drug_Cst)2022 Drug cost: $14,255 (USD; Tot_Drug_Cst)2023 Drug cost: $23,282 (USD; Tot_Drug_Cst)2024 Drug cost: $13,705 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153188$1,003
20163196$3,900
20173387$8,071
20181844$2,783
201940122$7,387
20203291$22,356
202142102$11,342
20223083$14,255
202358122$23,282
202444114$13,705

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
93970Ultrasound study of arm or leg veins with compression and maneuvers5258$155
93880Ultrasound of both sides of head and neck blood flow112156$152
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more234503$117
93923Complete ultrasound study of arm and leg arteries96134$100
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more84115$73

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ClopidogrelClopidogrel Bisulfate673,303$498

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.5$35,182AngioDynamics, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Milan Bajmoczi, M.D.?

Tedicare shows public-source Medicare data for Milan Bajmoczi, M.D. (NPI 1700012598), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Milan Bajmoczi, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Milan Bajmoczi, M.D.?

Milan Bajmoczi, M.D. is linked to FAIRBANKS VASCULAR SURGERY (billing NPI 1972240562) in the available physician profile data.

Does Milan Bajmoczi, M.D. have Open Payments data?

Milan Bajmoczi, M.D. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.